Abstract:Muscle wasting is often associated with chronic inflammation. Because tumor necrosis factor ␣ (TNF-␣) has been implicated as a major mediator of cachexia, its effects on C2C12 myocytes were examined. TNF-␣ activated nuclear factor-␬B (NF-␬B) and interfered with the expression of muscle proteins in differentiating myoblasts. Introduction of a mutant form of inhibitory protein ␬B␣ (I␬B␣) restored myo-genic differentiation in myoblasts treated with TNF-␣ or interleukin 1␤. Conversely, activation of NF-␬B by overexpression of I␬B kinase was sufficient to block myogenesis, illustrating the causal link between NF-␬B activation and inhibition of myogenic differentiation. The inhibitory effects of TNF-␣ on myogenic differentiation were reversible, indicating that the effects of the cytokine were not due to nonspecific toxicity. Treatment of differentiated myotubes with TNF-␣ did not result in a striking loss of muscle-specific proteins, which shows that myogenesis was selectively affected in the myoblast stage by TNF-␣. An important finding was that NF-␬B was activated to the same extent in differentiating and differentiated cells, illustrating that once myocytes have differentiated they become refractory to the effects of NF-␬B activation. These results demonstrate that inflammatory cytokines may contribute to muscle wasting through the inhibition of myogenic differentiation via a NF-␬B-dependent pathway.—Lan-matory cytokines inhibit myogenic differentiation through activation of nuclear factor-␬B. Muscle wasting, defined as the loss of skeletal muscle tissue, commonly occurs in chronic wasting syndromes, such as AIDS (1), cancer (2), chronic heart failure (3), and chronic obstructive pulmonary disease (4 – 6), and is an independent predictor of mortality. Remarkably, in many of these conditions muscle wasting is associated with chronic elevations in circulating inflamma-tory cytokines, in particular tumor necrosis factor ␣ (TNF-␣) (7–10). Muscle wasting is generally believed to result from disturbances in the energy or anabolism-catabolism balance. For example, imbalances in myofi-brillar protein synthesis and proteolysis have been demonstrated in experimental models of cancer ca-chexia (11, 12) and sepsis (13). Elevated levels of circulating inflammatory mediators, such as TNF-␣ and interleukin 1 (IL-1), were believed to trigger the events leading to muscle wasting in these models. In support of this, chronic administration of TNF-␣ or IL-1 induced weight loss and skeletal muscle wasting in rats (14). Muscle wasting may alternatively result from a decrease of the number of fibers. In support of this proposal, an increased prevalence of apoptotic myonu-clei has been associated with the loss of skeletal muscle tissue in muscular dystrophies and inflammatory myop-athies (15–17). In addition, …

Ion Current-Based Proteomic Profiling for Understanding the Inhibitory Effect of Tumor Necrosis Factor Alpha on Myogenic Differentiation.

Integrative Analysis of MicroRNA and Mrna Data Reveals an Orchestrated Function of MicroRNAs in Skeletal Myocyte Differentiation in Response to TNF-α or IGF1

[Effects of Tumor Necrosis Factor Alpha on Expression of Phospholamban and Intracellular Calcium in Cardiomyocytes].

Tumor Necrosis Factor Α Deficiency Promotes Myogenesis and Muscle Regeneration

TNF-α inhibits differentiation in porcine skeletal myoblast via ERK and MAPK

Tumor Necrosis Factor-Alpha Modulates Expression of Genes Involved in Cytokines and Chemokine Pathways in Proliferative Myoblast Cells

TNFR 2 Stimulation Promotes Mitochondrial Fusion Via Stat 3-and NF-kB – Dependent Activation of OPA 1 Expression

Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-␬b

Dose-Specific Effects of Tumor Necrosis Factor Alpha on Osteogenic Differentiation of Mesenchymal Stem Cells

TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A

Supplementary Methods from Membrane Versus Soluble Isoforms of TNF-α Exert Opposing Effects on Tumor Growth and Survival of Tumor-Associated Myeloid Cells

Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies

The role of TNF- in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment

14-3-3 Epsilon Dynamically Interacts with Key Components of Mitogen-Activated Protein Kinase Signal Module for Selective Modulation of the Tnf-Alpha-Induced Time Course-Dependent Nf-Kappa B Activity

Tumor Necrosis Factor-α Inhibits Bone Marrow Stem Cell Differentiation into Osteoblasts by Downregulating Microrna-34A Expression.

Inhibition of Tumor Necrosis Factor-Α-dependent Cardiomyocyte Apoptosis by Metallothionein

Aronia-derived anthocyanins and metabolites ameliorate TNFα-induced disruption of myogenic differentiation in satellite cells

The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment

Tu-P10:503 Metallothionein Suppression of NADPH Pxidase Activation is Involved in the Prevention of Angiotensin-Induced Cell Death

Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation

TGM2 positively regulates myoblast differentiation via enhancing the mTOR signaling